Micael Lopez-Acevedo

921 total citations
17 papers, 626 citations indexed

About

Micael Lopez-Acevedo is a scholar working on Oncology, Public Health, Environmental and Occupational Health and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Micael Lopez-Acevedo has authored 17 papers receiving a total of 626 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 7 papers in Public Health, Environmental and Occupational Health and 5 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Micael Lopez-Acevedo's work include Cancer survivorship and care (5 papers), Endometrial and Cervical Cancer Treatments (5 papers) and Childhood Cancer Survivors' Quality of Life (4 papers). Micael Lopez-Acevedo is often cited by papers focused on Cancer survivorship and care (5 papers), Endometrial and Cervical Cancer Treatments (5 papers) and Childhood Cancer Survivors' Quality of Life (4 papers). Micael Lopez-Acevedo collaborates with scholars based in United States, Belgium and India. Micael Lopez-Acevedo's co-authors include Katherine B. Chiappinelli, Aneil Srivastava, Sara Moufarrij, Stephanie Gomez, Alejandro Villagra, Paula S. Lee, Laura J. Havrilesky, Monica Dandapani, Elisa Arthofer and Angeles Alvarez Secord and has published in prestigious journals such as Cancer Research, Scientific Reports and Gynecologic Oncology.

In The Last Decade

Micael Lopez-Acevedo

17 papers receiving 620 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Micael Lopez-Acevedo United States 11 227 169 164 150 122 17 626
Xiaowei Xi China 15 205 0.9× 160 0.9× 268 1.6× 141 0.9× 74 0.6× 33 706
Anita Chudecka-Głaz Poland 17 227 1.0× 232 1.4× 123 0.8× 375 2.5× 196 1.6× 85 863
Fufan Zhu China 13 209 0.9× 55 0.3× 103 0.6× 49 0.3× 172 1.4× 22 578
Rochelle Demsky Canada 13 103 0.5× 231 1.4× 126 0.8× 246 1.6× 58 0.5× 25 686
Amy L. Gross United States 10 102 0.4× 154 0.9× 99 0.6× 289 1.9× 152 1.2× 14 538
Kathryn A. Maurer United States 12 120 0.5× 119 0.7× 50 0.3× 169 1.1× 252 2.1× 24 548
Charlotte Gerd Hannibal Denmark 18 106 0.5× 172 1.0× 141 0.9× 551 3.7× 266 2.2× 34 842
Monika Sobočan Slovenia 13 102 0.4× 62 0.4× 120 0.7× 55 0.4× 77 0.6× 47 423
Simona Moroni Italy 16 71 0.3× 180 1.1× 115 0.7× 328 2.2× 229 1.9× 20 665
Robin A. Lacour United States 11 76 0.3× 182 1.1× 32 0.2× 195 1.3× 155 1.3× 21 579

Countries citing papers authored by Micael Lopez-Acevedo

Since Specialization
Citations

This map shows the geographic impact of Micael Lopez-Acevedo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Micael Lopez-Acevedo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Micael Lopez-Acevedo more than expected).

Fields of papers citing papers by Micael Lopez-Acevedo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Micael Lopez-Acevedo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Micael Lopez-Acevedo. The network helps show where Micael Lopez-Acevedo may publish in the future.

Co-authorship network of co-authors of Micael Lopez-Acevedo

This figure shows the co-authorship network connecting the top 25 collaborators of Micael Lopez-Acevedo. A scholar is included among the top collaborators of Micael Lopez-Acevedo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Micael Lopez-Acevedo. Micael Lopez-Acevedo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Goyal, Sharad, et al.. (2022). Trends in guideline-adherent chemoradiation therapy for locally advanced cervical cancer before and after the affordable care act. Gynecologic Oncology. 166(1). 165–172. 1 indexed citations
2.
Sparks, Andrew, et al.. (2020). Trends in guideline-adherent fertility-sparing surgery for early-stage cervical cancer before and after the Affordable Care Act. Gynecologic Oncology. 158(2). 424–430. 4 indexed citations
3.
Moufarrij, Sara, Aneil Srivastava, Stephanie Gomez, et al.. (2020). Combining DNMT and HDAC6 inhibitors increases anti-tumor immune signaling and decreases tumor burden in ovarian cancer. Scientific Reports. 10(1). 3470–3470. 73 indexed citations
4.
Watson, Catherine, Micael Lopez-Acevedo, Gloria Broadwater, et al.. (2019). A pilot study of lower extremity lymphedema, lower extremity function, and quality of life in women after minimally invasive endometrial cancer staging surgery. Gynecologic Oncology. 153(2). 399–404. 16 indexed citations
5.
Moufarrij, Sara, Monica Dandapani, Elisa Arthofer, et al.. (2019). Epigenetic therapy for ovarian cancer: promise and progress. Clinical Epigenetics. 11(1). 7–7. 221 indexed citations
6.
Mark, Katrina, et al.. (2019). Rates of regression of cervical dysplasia between initial biopsy and excisional procedure in routine clinical practice. Archives of Gynecology and Obstetrics. 299(3). 841–846. 4 indexed citations
7.
8.
Lopez-Acevedo, Micael, Gregory P. Samsa, Paula S. Lee, et al.. (2018). Predicting 6- and 12-Month Risk of Mortality in Patients With Platinum-Resistant Advanced-Stage Ovarian Cancer. International Journal of Gynecological Cancer. 28(2). 302–307. 6 indexed citations
9.
Sherman, Jonathan H., et al.. (2017). Choriocarcinoma with brain, lung and vaginal metastases successfully treated without brain radiation or intrathecal chemotherapy: A case report. Gynecologic Oncology Reports. 20. 97–99. 11 indexed citations
10.
Lopez-Acevedo, Micael, Adam H. Buchanan, Angeles Alvarez Secord, et al.. (2017). Cost Comparison of Genetic Testing Strategies in Women With Epithelial Ovarian Cancer. Journal of Oncology Practice. 13(2). e120–e129. 10 indexed citations
11.
Ehrisman, Jessie, Angeles Alvarez Secord, Andrew Berchuck, et al.. (2016). Performance of sentinel lymph node biopsy in high-risk endometrial cancer. Gynecologic Oncology Reports. 17. 69–71. 44 indexed citations
12.
Lopez-Acevedo, Micael, L. Grace, Deanna Teoh, et al.. (2014). Dasatinib (BMS-35482) potentiates the activity of gemcitabine and docetaxel in uterine leiomyosarcoma cell lines. PubMed. 1(1). 2–2. 17 indexed citations
13.
Lopez-Acevedo, Micael, Laura J. Havrilesky, Gloria Broadwater, et al.. (2013). Timing of end-of-life care discussion with performance on end-of-life quality indicators in ovarian cancer. Gynecologic Oncology. 130(1). 156–161. 86 indexed citations
14.
Lopez-Acevedo, Micael, et al.. (2013). Palliative and hospice care in gynecologic cancer: A review. Gynecologic Oncology. 131(1). 215–221. 31 indexed citations
15.
Lowery, William J., et al.. (2013). Cost-effectiveness of early palliative care intervention in recurrent plati- num-resistant ovarian cancer. Gynecologic Oncology. 130(1). e29–e30. 1 indexed citations
16.
Lowery, William J., Jason C. Barnett, Micael Lopez-Acevedo, et al.. (2013). Cost-effectiveness of early palliative care intervention in recurrent platinum-resistant ovarian cancer. Gynecologic Oncology. 130(3). 426–430. 49 indexed citations
17.
Podzielinski, Iwona, Marcus E. Randall, Patrick Breheny, et al.. (2011). Primary radiation therapy for medically inoperable patients with clinical stage I and II endometrial carcinoma. Gynecologic Oncology. 124(1). 36–41. 51 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026